More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
Binding of immunogenic peptides to Ia histocompatibility molecules
1985 • 1,209 citations
Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding
1990 • 486 citations
Isolation and characterization of antigen-la complexes involved in T cell recognition
1986 • 470 citations
The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route
1990 • 445 citations
Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment
1990 • 377 citations
Role for intracellular proteases in the processing and transport of class II HLA antigens.
1988 • 336 citations
Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens
1982 • 308 citations
Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways
1990 • 303 citations
Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.
1991 • 234 citations
Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes.
1992 • 219 citations
Structural model of HLA-DR1 restricted T cell antigen recognition
1988 • 172 citations
Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules
1993 • 157 citations
Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
1982 • 155 citations
Identification of proteases that process distinct epitopes on the same protein.
1989 • 147 citations
Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
1993 • 145 citations
Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41
1992 • 124 citations
A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3).
1984 • 119 citations
Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
1990 • 113 citations
Binding to Ia protects an immunogenic peptide from proteolytic degradation.
1989 • 113 citations
The invariant chain of murine ia antigens: Its glycosylation, abundance and subcellular localization
1981 • 108 citations
Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines
1985 • 106 citations
HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.
1986 • 100 citations
Role of cathepsin D in antigen presentation of ovalbumin.
1992 • 93 citations
Selective inhibition of antigen presentation to cloned T cells by protease inhibitors
1989 • 84 citations
Invariant chain retains MHC class II molecules in the endocytic pathway.
1993 • 73 citations
Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.
1991 • 68 citations
Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii
1989 • 66 citations
Invariant chain alters the malignant phenotype of MHC class II+ tumor cells.
1992 • 61 citations
Proteolytic enzymes: A practical approach
1990 • 17 citations
Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
1985 • 12 citations
Binding of radioiodinated influenza virus peptides to class I MHC molecules and to other cellular proteins as analyzed by gel filtration and photoaffinity labeling
1991 • 8 citations